tiprankstipranks
Trending News
More News >
Maze Therapeutics, Inc. (MAZE)
NASDAQ:MAZE
US Market

Compare Maze Therapeutics, Inc. (MAZE) vs. Competitors

Compare
59 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Maze Therapeutics, Inc.
$41.39
$1.96B
-18.08
155.61%
7 Buy
0 Hold
0 Sell
Strong Buy
Cormedix
$6.78
$534.19M
3.30
-46.99%
6 Buy
0 Hold
0 Sell
Strong Buy
Geron
$1.31
$836.25M
-10.90
-55.14%
4 Buy
1 Hold
0 Sell
Strong Buy
KalVista Pharmaceuticals
$14.60
$737.98M
-3.65
76.97%
8 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$45.68
$1.26B
-16.20
203.93%
9 Buy
1 Hold
0 Sell
Strong Buy
Nuvation Bio
$5.85
$2.01B
-9.14
130.31%
9 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MAZE
Maze Therapeutics, Inc.
40.77
25.77
171.80%
CRMD
Cormedix
6.78
-5.71
-45.72%
GERN
Geron
1.31
-1.65
-55.74%
KALV
KalVista Pharmaceuticals
14.60
5.85
66.86%
ANAB
AnaptysBio
45.68
28.80
170.62%
NUVB
Nuvation Bio
5.85
3.27
126.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts